Atlas Trials

Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes

Clinical trial NCT03361631 · UNKNOWN

Trial details

NCT number
NCT03361631
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Erectile DysfunctionStem CellsDiabetes Mellitus, Type 1
Start date
2018-06-30
Primary completion
2018-07-30
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.